Mostrar el registro sencillo

dc.contributor.authorArmas-Rillo, Laura dees_ES
dc.contributor.authorQuevedo-Abeledo, Juan Carloses_ES
dc.contributor.authorHernández-Hernández, Vanesaes_ES
dc.contributor.authorVera-González, Antonia dees_ES
dc.contributor.authorGonzález-Delgado, Alejandraes_ES
dc.contributor.authorGarcía-Dopico, José A.es_ES
dc.contributor.authorGonzález-Gay Mantecón, Miguel Ángel es_ES
dc.contributor.authorFerraz-Amaro, Ivánes_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-04-05T18:11:49Z
dc.date.available2023-04-05T18:11:49Z
dc.date.issued2022es_ES
dc.identifier.issn1478-6354es_ES
dc.identifier.issn1478-6362es_ES
dc.identifier.otherPI17/00083es_ES
dc.identifier.urihttps://hdl.handle.net/10902/28480
dc.description.abstractBackground: Modulators of triglyceride metabolism include lipoprotein lipase (LPL), angiopoietin-like protein 4 (ANGPTL4), and apolipoprotein C-3 (ApoC3). There is evidence on the influence of this triangle of molecules on an increased risk of atherosclerotic cardiovascular disease (CV) in the general population. Patients with rheumatoid arthritis (RA) present changes in lipid profiles and accelerated CV disease. In the present study, we set out to study whether the ANGPTL4, ApoC3, and LPL axis differs in subjects with RA compared to controls. In a further step, we investigated the relationship of this axis with subclinical atherosclerosis in patients with RA. Methods: Cross-sectional study that included 569 individuals, 323 patients with RA and 246 age-matched controls. ANGPTL4, ApoC3 and LPL, and standard lipid profiles were analyzed in patients and controls. Carotid intima-media thickness (cIMT) and carotid plaques were assessed in RA patients. A multivariable analysis was performed to assess whether the ANGPTL4, ApoC3, and LPL axis was altered in RA and to study its relationship with RA dyslipidemia and subclinical carotid atherosclerosis. Results: Most lipid profile molecules did not differ between patients and controls. Despite this, and after fully multivariable analysis including CV risk factors, use of statins, and changes in the lipid profile caused by the disease itself, patients with RA showed higher serum levels of ANGPTL4 (beta coef. 295 [95% CI 213-376] ng/ml, p<0.001) and ApoC3 (beta coef. 2.9 [95% CI 1.7-4.0] mg/dl, p<0.001), but lower circulating LPL (beta coef. -174 [95% CI -213 to - 135] ng/ml, p<0.001). ANGPTL4 serum levels were positively and independently associated with a higher cIMT in patients with RA after fully multivariable adjustment. Conclusion: The axis consisting in ANGPTL4, ApoC3, and LPL is disrupted in patients with RA. ANGPTL4 serum levels are positively and independently associated with a higher cIMT in RA patients.es_ES
dc.description.sponsorshipFunding: This work was supported by a grant to IFA from the Spanish Ministry of Health, Subdirección General de Evaluación y Fomento de la Investigación, Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 and by Fondo Europeo de Desarrollo Regional - FEDER - (Fondo de Investigaciones Sanitarias, PI17/00083).es_ES
dc.format.extent11 p.es_ES
dc.language.isoenges_ES
dc.publisherBioMed Centrales_ES
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceArthritis Research & Therapy, 2022, 24, 99es_ES
dc.subject.otherRheumatoid arthritises_ES
dc.subject.otherDyslipidemiaes_ES
dc.subject.otherInflammationes_ES
dc.subject.otherLipoprotein lipasees_ES
dc.subject.otherAngiopoietin-like protein 4es_ES
dc.subject.otherApolipoprotein C3es_ES
dc.titleThe angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1186/s13075-022-02784-zes_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1186/s13075-022-02784-zes_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International